MedPath
HSA Approval

Apo-Sertraline 50mg Tablet

SIN13467P

Apo-Sertraline 50mg Tablet

Apo-Sertraline 50mg Tablet

May 15, 2008

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N06AB06

sertraline

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

Apotex Inc.

Active Ingredients

Sertraline (equivalent to sertraline hydrochloride 55.9mg)

50.0 mg

Sertraline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Apo-Sertraline 50mg Tablet - HSA Approval | MedPath